Format

Send to

Choose Destination
Regen Med. 2017 Sep;12(6):693-703. doi: 10.2217/rme-2017-0068. Epub 2017 Oct 4.

The European General Data Protection Regulation: challenges and considerations for iPSC researchers and biobanks.

Author information

1
Nuffield Department of Population Health, HeLEX - Center for Health, Law & Emerging Technologies, University of Oxford, Ewert House, Ewert Place, Banbury Road, Oxford OX2 7DD, UK.
2
Melbourne Law School, University of Melbourne, Parkville, VIC 3010, Australia.
3
School of Law, Kenyon Mason Institute for Medicine, Life Sciences & Law, University of Edinburgh, Old College, South Bridge, Edinburgh EH8 9YL, UK.
4
Department of Anatomy & Neuroscience, Stem Cells Center for Stem Cell Systems, University of Melbourne, Parkville, VIC 3010, Australia.

Abstract

Increasingly, human induced pluripotent stem cells (iPSC) and their associated genetic and clinical information are being used in a wide range of applications, with large biobanks being established to support and increase their scientific use. The new European General Data Protection Regulations, which comes into effect in 2018, will have implications for biobanks that generate, store and allow research access to iPSC. This paper describes some of the challenges that iPSC biobanks face and suggests some points for the development of appropriate governance structures to address these new requirements. These suggestions also have implications for iPSC research in general.

KEYWORDS:

biobanks; data protection; governance; induced pluripotent stem cells; stem cells

PMID:
28976812
PMCID:
PMC5857917
DOI:
10.2217/rme-2017-0068
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center